Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Targeted therapy for locally advanced and/or metastatic bladder cancer].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie - 1 Jul 2008

Wallerand H, Robert G, Bernhard J-C, Ravaud A, Ferrière J-M

Abstract excerpt

Cancer is a complex disease characterized by a multitude of molecular and genetic abnormalities affecting cell proliferation and differentiation, apoptosis, and mobility (invasion). Each of these alterations represents a potential target for the development of targeted therapy. These new therapies inhibit cell growth and are said to be "cytostatic" in contrast with conventional "cytotoxic" chemotherapy. As a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis Inhibitors
Share to Antibiotics, Antineoplastic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bevacizumab

Share to Erlotinib Hydrochloride

Share to Gefitinib

Share to Piperidines

Share to Sirolimus

Share to Trastuzumab

Source

Identifiers

PMID: 18602599
DOI: 10.1016/j.purol.2008.04.020

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Targeted therapy for locally advanced and/or metastatic bladder cancer].PMID 18602599Read ↗

Molecular Pathways in Invasive Bladder Cancer: New Insights Into Mechanisms, Progression, and Target IdentificationSemantic proximity Read ↗

Management of advanced bladder cancer in the era of targeted therapies.Semantic proximity Read ↗

Chemotherapy for metastatic bladder cancer.Semantic proximity Read ↗

Key signaling pathways in the muscle‐invasive bladder carcinoma: Clinical markers for disease modeling and optimized treatmentSemantic proximity Read ↗

[Gene therapies for bladder cancer].Semantic proximity Read ↗

Novel approaches in the management of bladder cancerSemantic proximity Read ↗

Molecular targets for the therapeutic manipulation of apoptosis in bladder cancer.Semantic proximity Read ↗

Systemic chemotherapy for patients with bladder cancer--current controversies and future directions.Semantic proximity Read ↗

[Perspectives for molecular diagnostics exemplified by urothelial bladder carcinoma].Semantic proximity Read ↗

CDK4/6 Inhibition Controls Proliferation of Bladder Cancer and Transcription of RB1Semantic proximity Read ↗

p53 and retinoblastoma pathways in bladder cancer.Semantic proximity Read ↗

Novel agents in invasive urothelial cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.